LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Monte Rosa Therapeutics To Present Preclinical Data On The Potential Of MRT-8102 11/8/2025 11:56:53 AM
  • Monte Rosa Therapeutics Q3 Net Loss $27.1 Mln; Collaboration Revenue $12.8 Mln 11/6/2025 8:00:12 AM
  • Wedbush Reiterates Monte Rosa Therapeutics, Inc. (GLUE) At Outperform With $19 Price Target 10/24/2025 11:17:00 PM
  • Wedbush Is Increasing Monte Rosa Therapeutics, Inc. (GLUE) FY 26 Rev. Estimate To 57.8 M From 24.0 M 9/15/2025 9:38:01 PM
  • Wedbush Is Increasing Monte Rosa Therapeutics, Inc. (GLUE) Q3 26 Rev. Estimate To 14.4 M From 8.0 M 9/15/2025 9:37:49 PM
  • Wedbush Is Increasing Monte Rosa Therapeutics, Inc. (GLUE) Q2 26 Rev. Estimate To 14.4 M From 8.0 M 9/15/2025 9:37:42 PM
  • Wedbush Is Raising Monte Rosa Therapeutics, Inc. (GLUE) Q1 26 Rev. Estimate To 14.4 M From 8.0 M 9/15/2025 9:37:34 PM
  • Wedbush Is Raising Monte Rosa Therapeutics, Inc. (GLUE) FY 25 Rev. Estimate To 127.1 M From 108.9 M 9/15/2025 9:37:20 PM
  • Wedbush Is Increasing Monte Rosa Therapeutics, Inc. (GLUE) Q4 25 Rev. Estimate To 14.4 M From 8.0 M 9/15/2025 9:37:08 PM
  • Wedbush Is Lowering Monte Rosa Therapeutics, Inc. (GLUE) Q3 25 Rev. Estimate To 4.5 M From 8.0 M 9/15/2025 9:36:53 PM
  • Wedbush Is Increasing Monte Rosa Therapeutics, Inc. (GLUE) FY 26 Estimate To -1.26 From -2.02 9/15/2025 9:36:23 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap